Exploring Developments in IgAN and FSGS
Howard Trachtman, MD, FASN
Richard Lafayette, MD, FACP
Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?
Stefan D. Anker, MD, PhD
John Cleland, MD
Piotr Ponikowski, MD, PhD, FESC, FHFA
PROTECT Study in IgAN: Topline Data
Jonathan Barratt, MD
Hyperkalemia in CKD and HFrEF…What Am I Missing?
George L. Bakris, MD, FAHA, FASN
David Bushinsky, MD
Lars Lund, MD
The CKD Patient: Thinking Beyond the Numbers and Dialysis
Loreto Gesualdo, MD, FERA
David Jayne, MD
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Clinical Implications of the Evidence from IV Iron Trials in Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
2023 ESC Guideline Updates: Where Are We with Iron Deficiency?
Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
Marco Metra, MD
Gianluigi Savarese, MD
A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Maria Luiza Caramori, MD, PhD, MSc
Ana Maria Cebrián-Cuenca, MD, PhD
Pam R. Taub, MD, FACC, FASPC
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA
Stephen J. Greene, MD, FACC, FHFSA
Appropriate CKD Referral to Specialists
Peter Lin MD, CCFP
Ikechi Okpechi
What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?
Ovidiu Chioncel, MD, PhD
Early Detection of CKD
Sri Lekha Tummalapalli, MD, MBA, MAS
Applying CKD Interventions
Joel Topf, MD
CKD Evaluation & Measurement
Magdalena Madero, MD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Jürgen Floege, MD
